Other

Roche Diagnostics Operations, Inc.

Roche Operations Ltd.

Roche Diabetes Care, Inc.

Computer Associates Think, Inc.

Moose Creative Management Pty Limited

Ca, Inc.

Biomerieux, Inc.

Pierce Biotechnology, Inc.

Premark Rwp Holdings, Inc.

Solae, LLC

Secureauth Corporation

Automated Monitoring and Control International, Inc.

F. Hoffmann-la Roche Ag

Steven Jerome Moore

Henning Groll

Michael J Celentano

James L Pauley

James M Rosborough

Randall K Riggles

Cullen Thomas Moore

Nathan Eugene Manlove

Venkata Satya Suresh Attili

Nadimpally Neha Varma

Nadimpally Satyavarahala Raju

Terry Allen Beaty

Abner D Joseph

John T Austera

Nicholas St Clair Max Heine

James Adam Skaates

Joost Sebastiaan Poulus

Vlasta Komorous-King

Nikolay Vladimirov

Garret Florian Grajek

Surbhi Desai

Michel A Cadio

Blaine Edward Ramey

Mark V Lambiase

Boguslawa Dworecki

Michael Joseph Blackburn

Michael Lee Brown

Craig E Smith

Craig J Lund

Carol Jane Batman

Marshall M Parker

Matthew K McMindes

Robin Peng

Kurt Klem

Timothy Peter Engelhardt

Duane Patrick Fridley

Ricky Lee Collins

Larry Lewis Lockridge

Howard Lynn Douglas

Richard Abbott

Patrick Riley

Michael B Derrick

Ronald William Mudrow

Randall Riggles

A method for amelioriation of, or prophylaxis against, a viral infection comprising administering to a patient in need of treatment a therapeutically effective amount of 5 aminolevulinic acid, optionally with at least one of cucumarin nano, zinc, vitamin C and methylene blue, and compositions thereof. Such compositions may be used for the treatment of coronavirus infections, including the SARS-CoV-2 virus, and/or rhinoviruses.

Viral infection treatment with 5-aminolevulinic acid

A method for operating a medical device includes activating a processor in the medical device in a low-power operating mode, measuring a first voltage level of the battery, applying at least one discharge pulse to the battery in response to the first voltage level of the battery being greater than a predetermined passivation minimum voltage threshold and less than a predetermined passivation maximum voltage threshold, measuring a second voltage level of the battery after the at least one discharge pulse, and operating the processor in the medical device in an increased-power operating mode to continue operation of the medical device only in response to the second voltage level being greater than or equal to a predetermined operating voltage threshold, the predetermined operating voltage threshold being greater than the predetermined passivation minimum voltage threshold and less than or equal to the predetermined passivation maximum voltage threshold.

Apparatus and method for battery passivation compensation in a medical device

Therapy for viral infections including the novel corona virus (COVID-19)

The present invention provides therapeutic combinations of 5-aminolevulinic acid, with at least one of: Vitamin C, curcumin, zinc, and methylene blue for the treatment of coronavirus infections, including the SARS-CoV-2 virus, and/or rhinoviruses. Optionally such compositions may comprise other dietary supplements and one or more pharmaceutically acceptable excipients and also process for preparing it. The composition can also include other antiviral agents.

Combination therapy for coronavirus infections including the novel corona virus (COVID-19)

Disclosed are puzzle devices for production of one or more puzzles. The puzzle devices can include a body and at least one input device. The body can include a plurality of panels, each panel configured to display one or more visual indicators. The at least one input device can include a plurality of panels, each panel configured to display a visual indicator. The at least one input device can move relative to the body to align one or more panels of the input device with one or more panels of the body. The body can further include a plurality of visual output devices configured to generate visual indicators on the plurality of panels of the body.

Puzzle device

Trophy display

Biodetection system

A sensor includes a non-conductive substrate and a circuit on the non-conductive substrate. The circuit includes a primary resistive element on the non-conductive substrate having a first end and a second end, wherein the primary resistive element has a predetermined configuration; a secondary resistive element on the non-conductive substrate having a plurality of taps connected to the primary resistive element at a plurality of predetermined connection points on the predetermined configuration, the plurality of predetermined connection points defining a plurality of unique resistive paths through at least a portion of the predetermined configuration; and the plurality of unique resistive paths having a plurality of resistance values, the plurality resistance values determined using a non-linear distribution function. A sensor is configured to perform at least one of quantitative and qualitative analysis of an analyte in a sample of fluid.

Encoded biosensors and methods of manufacture and use thereof

The present invention provides a test strip for measuring a signal of interest in a biological fluid when the test strip is mated to an appropriate test meter, wherein the test strip and the test meter include structures to verify the integrity of the test strip traces, to measure the parasitic resistance of the test strip traces, and to provide compensation in the voltage applied to the test strip to account for parasitic resistive losses in the test strip traces.

System and method for quality assurance of a biosensor test strip

An analyte test sensor strip is disclosed having information coded thereon as well as a method of forming the same and conducting an analyte test using the analyte test sensor strip. Information relating to an attribute of the strip or batch/lot of strips may be coded based on resistance values pertaining to electrical aspects of the strip, such as a primary resistive element and a secondary resistive element, the secondary resistive element having one of a plurality of states defined by a location of a closed tap to form a unique resistive path for the secondary resistive element that includes a portion of the primary resistive element depending on the location of the closed tap. The states may be formed on the strip by a secondary processing step in the manufacture of the strip in which a plurality of taps are severed leaving only one tap in a closed state.

An embeddable module for measuring a blood glucose level may be embedded in an external host and may comprise a host interface, a microcontroller, an ASIC, a temperature measuring element, and a measurement strip port. The host interface may permit electrical communication between the host and the microcontroller. The microcontroller and ASIC may communicate with each other and may work together to measure the blood glucose level of a blood sample. The measurement strip port may receive a removable measurement strip having the blood sample. The ASIC may communicate with the measurement strip port such that the ASIC may receive signals from the measurement strip port related to the blood glucose level of the blood sample. The temperature measuring element may be in electrical communication with the microcontroller and may measure the temperature of the module and transmit signals to the microcontroller related to the temperature of the module.

Embeddable modules for measuring blood glucose levels

A method and system for configuring a valid duration period for a digital certificate. The method includes assigning a positive numeric value for each certificate term. The positive numeric value assigned to each certificate term is representative of the valid duration period. The method continues by prompting a user of the client device to request one certificate term. The method may include transmitting the requested certificate term to a server. The certificate term requested is sent via a certificate request. The server is configured to convert the positive numeric value associated with the requested certificate term into a duration counter. The method may also include a certificate server receiving from the server, the certificate request including the duration counter. The certificate server is configured to digitally sign the certificate request. The method may conclude with the client device generating the digital certificate having the valid duration period correspond to the positive numeric value associated with the requested certificate term.

System and method for configuring a valid duration period for a digital certificate

Growing community of inventors

Newtown, CT, United States of America

Steven Jerome Moore